Uploaded by Reginald Uy

9TH FLOOR READINGS SWAN

advertisement

University of Cebu - Banilad

College of Nursing

A Reading On

Oral vs Intravenous Ciprofloxacin in the Initial Empirical Management of Severe

Pyelonephritis or Complicated Urinary Tract Infections.

In Partial Fulfillment of the requirements for the

Subject NCM 106: Medical Surgical Nursing: Patient – Centered Collaborative Care.

Submitted to:

MARIA ELIZABETH MENDOZA, RN, MAN

Submitted by:

Allen Roque Swan

References:

1.

Sobel JDKaye D Urinary tract infections. Mandell GLBennett JEDolin Reds.

Principles and

Practice of Infectious Diseases 4th ed. New York, NY Churchill

Livingstone1995;662- 690Google Scholar

2.

Kunin CM Urinary tract infections in females. Clin Infect Dis.

1994;181- 12Google

ScholarCrossref

3.

Stamm WEHooton TM Management of urinary tract infections in adults. N Engl J

Med.

1993;3291328- 1334Google ScholarCrossref

4.

Ronald ARNicolle LEHarding GKM Standards of therapy for urinary tract infections in adults. Infection.

1992;20(suppl 3)S164- S170Google ScholarCrossref

5.

Bacheller CDBernstein JM Urinary tract infections. Med Clin North

Am.

1997;81719- 730Google ScholarCrossref

6.

Bergeron MG Treatment of pyelonephritis in adults. Med Clin North

Am.

1995;79619- 649Google Scholar

7.

Harding GKMRonald AR The management of urinary tract infections: what have we learned in the past decade? Int J Antimicrob Agents.

1994;483- 88Google ScholarCrossref

8.

Hooton TMStamm WE Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am.

1991;75339- 357Google Scholar

9.

Wolfson JSHooper DC Treatment of genito-urinary tract infections with fluoroquinolones: activity in-vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis. Antimicrob Agents Chemother.

1989;331655- 1661Google ScholarCrossref

10.

Amyes SGBBaird DRCrook DW et al. A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens. J Antimicrob Chemother.

1994;34639- 648Google ScholarCrossref

11.

Ryan JLBerenson CSGreco TP et al. Oral ciprofloxacin in resistant urinary tract infections. Am J Med.

1987;82(suppl 4A)303- 306Google ScholarCrossref

12.

Fass RJ Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. Antimicrob Agents Chemother.

1987;31148- 150Google ScholarCrossref

13.

Preheim LCCuevas TARoccaforte JSMellencamp MABittner MJ Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria. Am J Med.

1987;82(suppl 4A)296- 300Google

Scholar

14.

Naber KGDi Silverio FGeddes AGuibert J Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection. J Antimicrob

Chemother.

1996;37(suppl A)135- 144Google ScholarCrossref

15.

Harding GNicolle LWenman W et al. Randomised comparison of oral ciprofloxacin vs standard parenteral therapy in the treatment of complicated urinary tract infections. Drugs.

1993;45(suppl 3)333- 334Google ScholarCrossref

16.

Bailey RRBegg EJSmith AH et al. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis. Clin

Nephrol.

1996;46183- 186Google Scholar

17.

Rubin RHShapiro EDAndriole VTDavis RJStamm WE General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect

Dis.

1992;15(suppl 1)S216- S227Google ScholarCrossref

18.

Bauer AWKirby WMMSherris JCTurck M Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol.

1966;45493- 496Google Scholar

19.

The ACCP/SCCM Consensus Conference Committee, Definitions for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis. Chest.

1992;1011644- 1655Google

ScholarCrossref

20.

Safrin SSiegel DBlack D Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med.

1988;85793- 798Google ScholarCrossref

21.

Cox CEMcCabe REGrad C Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection. Am J Med.

1987;82(suppl 6B)59- 64Google ScholarCrossref

22.

Angel JLO'Brien WFFinan MAMorales WJLake MKnuppel RA Acute pyelonephritis in pregnancy: a prospective study of oral versus intravenous antibiotic therapy. Obstet

Gynecol.

1990;7628- 32Google Scholar

23.

Grover SAKomaroff ALWeisberg MCook EFGoldman L The characteristics and hospital course of patients admitted for presumed acute pyelonephritis. J Gen Intern

Med.

1987;25- 10Google ScholarCrossref

24.

Johnson JRLyons FMF IIPearce W et al. Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days. J Infect Dis.

1991;163325- 330Google ScholarCrossref

25.

Patton JPNash DBAbrutyn E Urinary tract infection: economic considerations. Med Clin

North Am.

1991;75495- 513Google Scholar

Download